Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Osteoporos Int. 2014 May 27;25(9):2237–2244. doi: 10.1007/s00198-014-2754-x

Fig. 1.

Fig. 1

Study design showing the length of baseline, bed rest, and recovery periods for the AG study (a) and EX study (b). The times of the three doses of tracer administration are indicated by the arrows above the timeline for each study